{
    "organizations": [],
    "uuid": "3a8ce97eec28434cb06b8d265ab67e5e37c0f6cd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-egalet-announces-two-large-regiona/brief-egalet-announces-two-large-regional-health-plans-placed-arymo-er-in-preferred-formulary-position-idUSFWN1RU16N",
    "ord_in_thread": 0,
    "title": "BRIEF-Egalet Announces Two Large Regional Health Plans Placed Arymo® Er In Preferred Formulary Position",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Egalet Corp:\n* EGALET ANNOUNCES TWO LARGE NORTHEAST REGIONAL HEALTH PLANS PLACED ARYMO® ER IN PREFERRED FORMULARY POSITION\n* EGALET CORP - TWO LARGE NORTHEAST REGIONAL HEALTH PLANS HAVE PLACED ARYMO ER EXTENDED-RELEASE TABLETS FOR ORAL USE ONLY -CII IN PREFERRED FORMULARY POSITION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-18T04:34:00.000+03:00",
    "crawled": "2018-04-18T18:12:49.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "egalet",
        "corp",
        "egalet",
        "announces",
        "two",
        "large",
        "northeast",
        "regional",
        "health",
        "plan",
        "placed",
        "er",
        "preferred",
        "formulary",
        "position",
        "egalet",
        "corp",
        "two",
        "large",
        "northeast",
        "regional",
        "health",
        "plan",
        "placed",
        "arymo",
        "er",
        "tablet",
        "oral",
        "use",
        "preferred",
        "formulary",
        "position",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}